Doxazosin Mesylate description, usages, side effects, indications, overdosage, supplying and lots more!

Doxazosin Mesylate

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DESCRIPTION

INACTIVE INGREDIENT

CLINICAL PHARMACOLOGY

PHARMACODYNAMICS

MECHANISM OF ACTION

PHARMACOKINETICS

PRECAUTIONS

CONTRAINDICATIONS

WARNINGS

INFORMATION FOR PATIENTS

DRUG INTERACTIONS

PREGNANCY

TERATOGENIC EFFECTS

NONTERATOGENIC EFFECTS

NURSING MOTHERS

PEDIATRIC USE

GERIATRIC USE

CLINICAL STUDIES

ADVERSE REACTIONS

OVERDOSAGE

HOW SUPPLIED

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL














PACKAGE LABEL.PRINCIPAL DISPLAY PANELPACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Doxazosin Mesylate

Doxazosin Mesylate TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-004(NDC:60505-0093)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DOXAZOSIN MESYLATE DOXAZOSIN 1 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
lactose monohydrate
SODIUM STARCH GLYCOLATE TYPE A POTATO
MAGNESIUM STEARATE
STARCH, CORN
SODIUM LAURYL SULFATE

Product Characteristics

Color Size Imprint Code Shape
white 2 mm apo;093 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-004-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075580 2010-07-29


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.